PCI
Clinical trials for PCI explained in plain language.
Never miss a new study
Get alerted when new PCI trials appear
Sign up with your email to follow new studies for PCI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart surgery showdown: which procedure wins for weak hearts?
Disease control Recruiting nowThis study compares two common heart procedures—bypass surgery (CABG) and stenting (PCI)—in 358 people with weak hearts (low pumping function) and multiple blocked arteries. The goal is to see which approach leads to better survival, fewer heart attacks or strokes, and improved q…
Matched conditions: PCI
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
Heart stent study tests smarter imaging to prevent repeat blockages
Disease control Recruiting nowThis study compares two ways to treat heart stents that have narrowed again after drug-eluting stent placement. About 1500 adults with this condition will receive either standard angiography guidance or advanced intravascular imaging guidance during a repeat procedure. The goal i…
Matched conditions: PCI
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New balloon technique takes on Rock-Hard arteries in heart disease trial
Disease control Recruiting nowThis study tests whether a super high-pressure balloon or a special shockwave device (intravascular lithotripsy) works better to crack open severely calcified coronary arteries before placing a stent. About 78 adults with hardened heart arteries will be randomly assigned to one o…
Matched conditions: PCI
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Could a diabetes drug calm inflammation after heart stenting?
Knowledge-focused Recruiting nowThis study looks at whether empagliflozin, a diabetes drug, can lower inflammation after a heart stent procedure. About 100 people with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers wi…
Matched conditions: PCI
Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC